LAG3 is a key warrantor of immuno-tolerance, to the point that inhibitory monoclonal antibodies are currently approved for cancer immunotherapy.33 The gene SERPING1 encodes the C1 esterase inhibitor, which inhibits both the classical and lectin complement pathways. Here, LAG3 is linked to cancer.